The safety and bone antiresorptive effect of a single subcutaneous dose of AMG 162, a
human monoclonal antibody to RANKL, was investigated in 49 postmenopausal women. AMG …

… The table also presents the p values for the comparison between each OPG group and the
placebo group and the corresponding 95% CIs for the difference in the means, adjusted for …

… Asterisk indicates p < 0.05 for change from baseline vs. celecoxib and placebo. None of the
differences between celecoxib and placebo was statistically significant at any postdose time …

… Peter Leese Senior Lecturer in Social and Cultural History, Jagiellonian University … My
special thanks go to Elżbieta Wójcik-Leese and to Tomasz Adam Wójcik-Leese for their …

This pharmacodynamic study examined weight-based dosing of the low molecular weight
heparin (LMWH), tinzaparin, in heavyweight/obese subjects. Single doses (175 and 75 IU/kg) …

Long COVID, or complications arising from COVID-19 weeks after infection, has become a
central concern for public health experts. The United States National Institutes of Health …

Purpose Osimertinib (AZD9291) 80 mg once daily is approved by the US FDA for the treatment
of patients with metastatic EGFR T790M-positive NSCLC whose disease has previously …

The pharmacokinetics, safety, and tolerability of oral moxifloxacin, a new 8-methoxy quinolone,
were assessed in a randomized, double-blind, placebo-controlled study in which healthy …

… per cent of those treated with EGF compared with 11 per cent receiving placebo (P = 0·1),
with a reduction in ulcer size of 73 versus 33 per cent (P = 0·32) by 10 weeks 26 . A cross-over …

The first human MR imaging results for the hepatobiliary contrast agent manganese(II)N,N'-dipyridoxylethylenediamine-N,N'-diacetate
5,5'-bis(phosphate) (MnDPDP) are reported. …